| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.832 | 0.011 | 0.879 | Antiinflammatory | 0.879 0.006 DBMET00306 | DBMET00306 | |
| 0.795 | 0.003 | 0.795 | Cyclooxygenase 1 inhibitor | 0.795 0.003 DBMET00306 | ||
| 0.764 | 0.008 | 0.9 | Analgesic | 0.9 0.004 DBMET00306 | DBMET00306 | |
| 0.619 | 0.004 | 0.619 | Cyclooxygenase inhibitor | 0.577 0.004 DBMET00306 | ||
| 0.565 | 0.005 | 0.565 | Non-steroidal antiinflammatory agent | 0.341 0.021 DBMET00306 | ||
| 0.531 | 0.015 | 0.531 | Lipoxygenase inhibitor | 0.291 0.076 DBMET00306 | ||
| 0.5 | 0.032 | 0.719 | Toll-Like receptor 7 agonist | 0.719 0.008 DBMET00306 | DBMET00306 | |
| 0.492 | 0.033 | 0.711 | Toll-Like receptor agonist | 0.711 0.008 DBMET00306 | DBMET00306 | |
| 0.508 | 0.078 | 0.508 | Alpha-glucosidase inhibitor | 0.248 0.189 DBMET00306 | ||
| 0.377 | 0.007 | 0.382 | Cyclooxygenase 2 inhibitor | 0.382 0.006 DBMET00306 | DBMET00306 | |
| 0.185 | 0.123 | 0.185 | RNA-directed DNA polymerase inhibitor | 0.166 0.16 DBMET00306 | ||
| 0.066 | 0.005 | 0.066 | Protocollagen prolyl hydroxylase inhibitor | |||
| 0.165 | 0.107 | 0.165 | Focal adhesion kinase 2 inhibitor | |||
| 0.129 | 0.076 | 0.129 | CC chemokine 6 receptor antagonist | 0.124 0.096 DBMET00306 | ||
| 0.043 | 0.021 | 0.043 | MAP3K5 inhibitor | |||
| 0.07 | 0.05 | 0.07 | 5 Hydroxytryptamine 1F antagonist | |||
| 0.071 | 0.053 | 0.071 | Histone deacetylase stimulant | |||
| 0.071 | 0.053 | 0.071 | Histone deacetylase SIRT1 stimulant | |||
| 0.033 | 0.026 | 0.033 | Glutamate (mGluR4) agonist | |||
| 0.023 | 0.022 | 0.023 | 5 Hydroxytryptamine 1F agonist | |||
| 0.02 | 0.065 | 0.093 | Nicotinic acid receptor 2 agonist | 0.093 0.006 DBMET00306 | DBMET00306 | |
| 0.013 | 0.099 | 0.032 | Nicotinic acid receptor agonist | 0.032 0.031 DBMET00306 | DBMET00306 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |